# COVID-19 SARS-CoV-2 RAST Study

> **NCT06452056** · — · COMPLETED · sponsor: **Columbia University** · enrollment: 337 (actual)

## Conditions studied

- SARS-CoV2 Infection

## Interventions

- **DEVICE:** Rapid Antigen Screening Test

## Key facts

- **NCT ID:** NCT06452056
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-07
- **Primary completion:** 2022-12-30
- **Final completion:** 2022-12-30
- **Target enrollment:** 337 (ACTUAL)
- **Last updated:** 2024-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06452056

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06452056, "COVID-19 SARS-CoV-2 RAST Study". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06452056. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*